2023-11-20 from cbc.ca

A Winnipeg nurse is seeking class-action status for her lawsuit against several top drug companies, accusing them of profiting for decades by marketing non-prescription oral decongestant medications containing an active ingredient that several studies have found ineffective.

Barb Eori's lawsuit claims nearly 50 years of alleged negligent misrepresentation of the drug phenylephrine as an effective pill-form nasal decongestant, breaching the Food and Drugs Act and several consumer protection and/or business practice laws.

The companies named in the suit, filed with Manitoba Court of King's Bench on Nov. 10, are Johnson & Johnson, Pfizer Canada, Procter & Gamble and GlaxoSmithKline Consumer Healthcare.

Read more here